![Ada M. Kruisbeek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ada M. Kruisbeek
Nessuna posizione attualmente
Profilo
Ada M.
Kruisbeek is the founder of DCPrime BV, which was founded in 2005.
She held the title of Chief Executive & Scientific Officer.
Dr. Kruisbeek's former jobs include Director-Cancer Center at Vrije Universiteit Amsterdam, Director at BruCells NV, Director at Stichting Onderzoek Cancer Center Amsterdam, Senior Vice President-Research at Crucell NV, Principal at National Institutes of Health, and Head-Immunology Department at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh.
Precedenti posizioni note di Ada M. Kruisbeek
Società | Posizione | Fine |
---|---|---|
Stichting Onderzoek Cancer Center Amsterdam | Direttore/Membro del Consiglio | 01/01/2005 |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
![]() Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Corporate Officer/Principal | 01/01/2001 |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/1992 |
Vrije Universiteit Amsterdam | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
BruCells NV
![]() BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Health Technology |
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Health Technology |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
![]() Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Miscellaneous |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Stichting Onderzoek Cancer Center Amsterdam | Miscellaneous |
- Borsa valori
- Insiders
- Ada M. Kruisbeek